Health and Healthcare
1067 Articles
The March 29 short interest data have been compared with the previous figures, and short interest in most of these…
Merck, Intel, JPMorgan Chase, and IBM led the Dow to a gain on Monday.
Shares of Merck had a boost early Monday after the firm announced that its Phase 3 trial of Keytruda for…
Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage…
Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial…
Merck and Walmart were among Wednesday's biggest gainers on the Dow while Intel and Cisco were among the big losers.
The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…
The Stifel view is that it is time for investors to take a more defensive posture, but that doesn’t mean…
The February 28 short interest data have been compared with the previous figures, and short interest in most of these…
The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…
The Dow dropped in Tuesday trading, led by downturns at Disney, Merck, Nike, and DowDuPont.
Walmart, General Electric, Merck, and Verizon were biggest losers on the DJIA Tuesday.
The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected…
Four large-cap pharmaceutical leaders are rated Overweight at JPMorgan, and all make sense for growth accounts looking for some safety…
Merck reported mixed fourth-quarter financial results before the markets opened on Friday.
Our top personal finance-related articles today. Your wallet will thank you later.